Page last updated: 2024-12-06

14-methylhexadecanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

14-methylhexadecanoic acid, also known as **myristopalmitic acid**, is a branched-chain fatty acid.

Here's a breakdown:

* **Structure:** It has a 16-carbon chain with a methyl group (CH3) attached to the 14th carbon atom. The carboxylic acid group (-COOH) is located at the end of the chain.
* **Occurrence:** It's naturally found in small amounts in some animal fats and oils, including those from cows, sheep, and pigs.
* **Synthesis:** It can also be synthesized artificially.

**Why is it important for research?**

14-methylhexadecanoic acid has attracted attention in various research fields, including:

* **Biochemistry:** Its unique structure and presence in certain lipids make it interesting for studies on lipid metabolism, membrane fluidity, and the role of branched-chain fatty acids in biological processes.
* **Biomedical Research:** Research has suggested potential connections between 14-methylhexadecanoic acid and various health conditions. For example:
* **Cancer:** Studies have investigated its potential role in tumor growth and development.
* **Cardiovascular Disease:** Research has explored its influence on cholesterol levels and heart health.
* **Neurological Disorders:** Some studies have suggested a link to neurological function.
* **Food Chemistry:** Its presence in certain food sources has led to research on its potential impact on food quality and flavor.
* **Materials Science:** 14-methylhexadecanoic acid's chemical properties can be useful in developing new materials with specific characteristics.

**Ongoing Research:**

There is ongoing research to further understand the properties, roles, and potential applications of 14-methylhexadecanoic acid. This research will likely shed more light on its biological significance and potential applications in various fields.

It's crucial to note that research on 14-methylhexadecanoic acid is still relatively limited. Further studies are needed to fully understand its implications for human health and other areas of interest.

14-methylhexadecanoic acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

14-methylhexadecanoic acid : A methyl-branched fatty acid that is hexadecanoic acid (palmitic acid) substituted by a methyl group at position 14. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID22207
CHEBI ID84874
SCHEMBL ID347119
MeSH IDM0133838

Synonyms (18)

Synonym
14-methylhexadecanoic acid
anteisoheptadecanoic acid
14-methyl-hexadecanoic acid
anteisomargaric acid
(+)-14-methyl palmitic acid
LMFA01020011
14-methylpalmitic acid
CHEBI:84874
hexadecanoic acid, 14-methyl-
5918-29-6
SCHEMBL347119
FXUKWLSZZHVEJD-UHFFFAOYSA-N
Q27158141
[1,3,5]triazine-2,4,6-trithiol
DTXSID60974612
CS-0083720
PD078020
HY-121940
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
mammalian metaboliteAny animal metabolite produced during a metabolic reaction in mammals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
methyl-branched fatty acidAny branched-chain fatty acid containing methyl branches only.
branched-chain saturated fatty acidAny saturated fatty acid with a carbon side-chain or isopropyl termination.
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (50.00)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.89 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]